Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS).
about
Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice.Sorafenib in thyroid cancer patients: learning from toxicity.
P2860
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Fractionation of daily dose in ...... uced hand-foot syndrome (HFS).
@en
Fractionation of daily dose in ...... nib-induced hand-foot syndrome
@nl
type
label
Fractionation of daily dose in ...... uced hand-foot syndrome (HFS).
@en
Fractionation of daily dose in ...... nib-induced hand-foot syndrome
@nl
prefLabel
Fractionation of daily dose in ...... uced hand-foot syndrome (HFS).
@en
Fractionation of daily dose in ...... nib-induced hand-foot syndrome
@nl
P2093
P2860
P1476
Fractionation of daily dose in ...... uced hand-foot syndrome (HFS).
@en
P2093
Audrey Thomas-Schoemann
Benoit Blanchet
François Goldwasser
Gilles Freyer
Michel Tod
Michel Vidal
Pascaline Boudou-Rouquette
P2860
P2888
P304
P356
10.1007/S00280-013-2352-1
P577
2013-11-20T00:00:00Z